Rothman Institute of Orthopedics at Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
J Arthroplasty. 2013 Mar;28(3):517-20. doi: 10.1016/j.arth.2012.06.040. Epub 2012 Nov 8.
The aim of this study was to evaluate the incidence of early mortality and identify risk factors for early death following modern uncemented THA. Between 2000 and 2006, we identified patients who died within 90days of THA. Demographics, comorbidities, laboratory studies, and complications were analyzed as risk factors for mortality. 38 of 8261 patients undergoing THA (0.46%) died within 90days postoperatively. Of these, 26% were due to myocardial infarction. Multivariate analysis revealed Charlson index >3, peripheral vascular disease, elevated postoperative glucose, and abnormal postoperative cardiac studies as independent predictors of early mortality following THA. Caution should be taken in patients with increased comorbidities, PVD, perioperative hyperglycemia, and impaired renal function in order to reduce mortality following THA.
本研究旨在评估现代非骨水泥 THR 后早期死亡率,并确定早期死亡的危险因素。在 2000 年至 2006 年间,我们确定了术后 90 天内死亡的患者。分析了人口统计学、合并症、实验室研究和并发症作为死亡率的危险因素。在接受 THR 的 8261 名患者中,有 38 名(0.46%)在术后 90 天内死亡。其中,26%死于心肌梗死。多变量分析显示,Charlson 指数>3、外周血管疾病、术后高血糖和术后心脏检查异常是 THR 后早期死亡的独立预测因素。对于合并症增加、PVD、围手术期高血糖和肾功能受损的患者,应谨慎操作,以降低 THR 后的死亡率。